SEC Form D · filed February 26, 2021
Xilio Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (31)
Daniel Curran · Waltham, MADirectorMichael Ross · Waltham, MADirectorJoseph Farmer · Waltham, MAExecPaul Clancy · Waltham, MADirectorRene Russo · Waltham, MAExec · DirectorTimothy Clackson · Waltham, MAExecDaniel Lynch · Waltham, MADirectorDavid Grayzel · Waltham, MADirectorRachel Humphrey · Waltham, MADirectorMatthew Butcher · Longmont, CODirectorJeff Feinstein · SEATTLE, WADirectorIvana Faltysova · GRAND CAYMAN, Cayman IslandsDirectorLeo Backer · SEATTLE, WADirectorDaniel A. Charna · Powell, OHExec · DirectorSrini A. Surendranath · Powell, OHExecMatthew A. Jones · Powell, OHDirectorRiyaz Nooruddin · GRAND CAYMAN, Cayman IslandsDirectorSheri C. Jones · Powell, OHExecAndrew Hack · Cambridge, MADirectorDavid Gardner · Rochester, NYDirectorJeffrey Williams · Dallas, TXDirectorCarl Sparks · Dallas, TXDirectorScale Venture Capital Management Group LLC · Dover, DEDirectorJoshua Owen · Raleigh, NCDirectorEvan Edwards · Raleigh, NCExecKevin Mosley · Raleigh, NCExec · DirectorJeffrey Williams · Raleigh, NCExecSerge De Reus · Amsterdam, P7DirectorPriyanka Chopra · San Francisco, CADirectorAndrew Hack · Cambridge, MADirectorDavid Gardner · Hillsborough, NJDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗